Work

Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia

Year: 2020

Type: article

Study design: Clinical Trial

Source: International Journal of Hematology

DOI: 10.1007/s12185-020-02994-8

Authors: Jorge Cortes, Nikolai Podoltsev, Hagop Kantarjian, Gautam Borthakur, Amer M. Zeidan, Maximilian Stahl, Tillmann Taube, Nora Fagan, Sushmita Rajeswari, Geoffrey L. Uy

Institutions: The University of Texas MD Anderson Cancer Center, Yale University, Boehringer Ingelheim (Germany), Boehringer Ingelheim (United States), Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Boehringer Ingelheim

OpenAlex ID: W3087629880

FWCI: 2.525

Cites: 38

Cited by: 23

Related to: 10